Livongo Health Inc (OQ:LVGO)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 150 W Evelyn Ave
Tel: 1-617-6157712
IR: See website
Key People
Glen E. Tullman
Executive Chairman of the Board
Jennifer J Schneider
Zane M. Burke
Chief Executive Officer, Director
Lee A. Shapiro
Chief Financial Officer
James Pursley
Chief Commercial Officer
Business Overview
Livongo Health, Inc. is a consumer digital health company. The Company offers Enter Livongo platform, which leverages data science and technology, creates a personalized experience for people with chronic conditions. The Company focuses on developing an approach for diabetes management that combines technology with coaching. The Company's Livongo platform offers a range of solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. The Company uses a digital approach to delivering evidence-based interventions including cognitive behavioral therapy, acceptance and commitment therapy, positive psychology, mindfulness, and motivational interviewing to help resolve clinical conditions, build resiliency, manage stress, improve mood, sleep better, or simply find daily inspiration.
Financial Overview
For the three months ended 31 March 2020, Livongo Health Inc revenues increased from $32.1M to $68.8M. Net loss applicable to common stockholders decreased 61% to $5.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Stock-Based Compensation in General and decrease of 25% to $3.7M (expense), Other income.
Employees: 671 as of Mar 31, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $7,225M as of Mar 31, 2020
Annual revenue (TTM): $206.96M as of Mar 31, 2020
EBITDA (TTM): -$43.78M as of Mar 31, 2020
Net annual income (TTM): -$45.94M as of Mar 31, 2020
Free cash flow (TTM): -$53.28M as of Mar 31, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 97,817,000 as of Apr 30, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization